Nitrosylcobalamin Enhances Chemotherapy Effects
Author Information
Author(s): Bauer Joseph A., Lupica Joseph A., Schmidt Heidi, Morrison Bei H., Haney Rebecca M., Masci Rhonda K., Lee Rebecca M., DiDonato Joseph A., Lindner Daniel J.
Primary Institution: The Cleveland Clinic Foundation
Hypothesis
Can nitrosylcobalamin (NO-Cbl) enhance the anti-tumor effects of chemotherapeutic agents?
Conclusion
NO-Cbl can enhance the effectiveness of chemotherapy by inhibiting survival signaling pathways.
Supporting Evidence
- 78% of the drug combinations tested showed a synergistic anti-proliferative effect.
- NO-Cbl pre-treatment decreased NF-κB DNA binding activity.
- NO-Cbl inhibited IκB kinase activity and AKT activation.
- Combination treatment resulted in a 99.01% reduction in tumor volume in vivo.
Takeaway
This study shows that a special form of vitamin B12 can help cancer treatments work better by stopping cancer cells from surviving.
Methodology
The study used anti-proliferative assays, EMSA, immunoblot analysis, and kinase assays to evaluate the effects of NO-Cbl with various chemotherapeutic agents.
Statistical Information
P-Value
0.000012
Confidence Interval
95% CI = 60.90% to 69.81%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website